How Will We Be Treating Cystic Fibrosis 10 Years From Now?
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
22/11/2021 - 9 minutes
Gene Therapy: A Rapidly Evolving Industry
As one of the biggest success stories of the 21st century, gene therapy is providing hope for treating diseases that once seemed incurable. Any genetic mutation causing disease could theoretically be fixed by inserting a new copy of the faulty gene. This means that gene therapy has the potential to treat some previously incurable conditions with a single dose.
By 2025, the FDA expects to approve between 10 and 20 gene therapies each year, and we are already seeing an increase in the number of approvals today. However, the field continues to face a number of obstacles ranging from safety concerns to manufacturing shortages. Read on to get the latest in the gene therapy field.
Show More
Gene Therapy Industry Report 2021
In this report, we take a closer look at the growing gene therapy market, current development and manufacturing challenges, and the exciting future ahead for this industry.
Go to ReportLatest Gene therapy Articles
Sponsored
by Merck
Gene therapy: Making Rare Disease Therapies Less Rare
While individually uncommon, rare diseases collectively impact the lives of over 300 million people worldwide.…
15/11/2021 - 2 minutes
Sponsored
by Merck
The Evolving Role of Automation in Gene Therapy Manufacturing
Today, large-scale gene therapy manufacturing faces challenges such as mounting regulatory requirements and the need…
09/11/2021 - 7 minutes
Skilled Labor Shortages Impact Cell And Gene Therapy Manufacturing
Despite vast amounts of funding entering the cell and gene therapy field, the manufacture of…
04/11/2021 - 5 minutes
Sponsored
by OXGENE
Plasmids: How to Solve a Bottleneck in Scalable Gene Therapy Manufacturing?
As gene therapies become increasingly successful, companies are in a competitive race to deliver manufacturing…
26/10/2021 - 7 minutes
Sponsored
by Merck
How to Develop a Robust Viral Safety Strategy for Gene Therapies
Gene therapies offer a promising hope of cure against rare diseases and other diseases like…
06/10/2021 - 8 minutes
Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain
Although most gene therapy still relies on non-infectious viral vectors for delivery, a recent venture…
04/10/2021 - 5 minutes
Sofinnova Taps into Italian Gene Therapy with Three Seed Financings
The French investor Sofinnova Partners has injected a total of €6M into three Italian gene…
12/07/2021 - 5 minutes
The Top European Biotech Funding Rounds in June
While oncology and psychedelics dominated European biotech’s biggest funding rounds last month, startup seed financing…
08/07/2021 - 5 minutes
Delayed IPOs and Market Drops Batter Biotech Stocks
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
25/05/2021 - 6 minutes
Bluebird Bio Withdrawal Raises Gene Therapy Doubts in Europe
Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo…
04/05/2021 - 5 minutes
Covid-19 Vaccine Approvals Bring Hope and Challenges for Adenoviral Technology
The rise of adenoviral Covid-19 vaccines highlights the potential of companies using similar technology in…
25/03/2021 - 6 minutes
